in Medical Countermeasures SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox
in Antimicrobial Resistance, Medical Countermeasures, Pathogens, Research Focus on Melioidosis: Highlighted News and Research
in Medical Countermeasures, Pathogens Soligenix Receives European and Canadian Patents for Ricin Toxin Vaccine
in Featured, Industry News, Medical Countermeasures Anti-Ricin Monoclonal Antibody Licensed for Development
in Featured, Policy & Initiatives, Preparedness, Public Health Health and Human Services Biodefense Budget Oversight
